Revenue: S$2.50m (down 14% from 3Q 2023).
Net loss: S$784.0k (loss narrowed by 95% from 3Q 2023).
S$0.001 loss per share (improved from S$0.025 loss in 3Q 2023).
Catalist:1H3 Earnings and Revenue History November 17th 2024
All figures shown in the chart above are for the trailing 12 month (TTM) period
Clearbridge Health shares are down 50% from a week ago.
You should learn about the 4 warning signs we’ve spotted with Clearbridge Health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.